HIV latency: Experimental systems and molecular models

FEMS Microbiology Reviews

Volumn 36, Issue 3, 2012, Pages 706-716

  Hakre, Shweta ^a   Chavez, Leonard ^a   Shirakawa, Kotaro ^a   Verdin, Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chromatin; Heterochromatin; Latency; Primary latency models; Repression; Virus

Indexed keywords

CD69 ANTIGEN; CHEMOKINE RECEPTOR CCR7; HETEROCHROMATIN PROTEIN 1; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; INTERLEUKIN 2 RECEPTOR ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; SECONDARY LYMPHOID TISSUE CHEMOKINE; TRANSCRIPTION FACTOR YY1;

CD25+ T LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; EPIGENETICS; HETEROCHROMATIN; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE UBIQUITINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR MODEL; NONHUMAN; PROTEIN PROCESSING; REVIEW; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; VIRUS LATENCY; VIRUS LOAD; VIRUS REACTIVATION; VIRUS TRANSCRIPTION;

GENE EXPRESSION REGULATION, VIRAL; HIV; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; MODELS, MOLECULAR; T-LYMPHOCYTES; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 84859373016     PISSN: 01686445     EISSN: 15746976     Source Type: Journal    
DOI: 10.1111/j.1574-6976.2012.00335.x     Document Type: Review

References (54)

1. Agbottah E, Deng L, Dannenberg LO, Pumfery A & Kashanchi F (2006) Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription. Retrovirology 3: 48.
2. Agosto LM, Yu JJ, Dai J, Kaletsky R, Monie D & O'Doherty U (2007) HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration. Virology 368: 60-72.
3. Benkirane M, Chun RF, Xiao H, Ogryzko VV, Howard BH, Nakatani Y & Jeang KT (1998) Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J Biol Chem 273: 24898-24905.
4. Blazkova J, Trejbalova K, Gondois-Rey F et al. (2009) CpG methylation controls reactivation of HIV from latency. PLoS Pathog 5: e1000554.
5. Bosque A & Planelles V (2009) Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells. Blood 113: 58-65.
6. Brooks DG, Arlen PA, Gao L, Kitchen CM & Zack JA (2003) Identification of T cell-signaling pathways that stimulate latent HIV in primary cells. P Natl Acad Sci USA 100: 12955-12960.
7. Cheutin T, McNairn AJ, Jenuwein T, Gilbert DM, Singh PB & Misteli T (2003) Maintenance of stable heterochromatin domains by dynamic HP1 binding. Science 299: 721-725.
8. Chomont N, El-Far M, Ancuta P et al. (2009) HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 15: 893-900.
9. Chun TW, Engel D, Mizell SB, Ehler LA & Fauci AS (1998) Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines. J Exp Med 188: 83-91.
10. Colin L & Van Lint C (2009) Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies. Retrovirology 6: 111.
11. Coull JJ, Romerio F, Sun JM et al. (2000) The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. J Virol 74: 6790-6799.
12. Dai J, Agosto LM, Baytop C, Yu JJ, Pace MJ, Liszewski MK & O'Doherty U (2009) Human immunodeficiency virus integrates directly into naive resting CD4+ T cells but enters naive cells less efficiently than memory cells. J Virol 83: 4528-4537.
13. Deere JD, Schinazi RF & North TW (2011) Simian immunodeficiency virus macaque models of HIV latency. Curr Opin HIV AIDS 6: 57-61.
14. du Chene I, Basyuk E, Lin YL et al. (2007) Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency. EMBO J 26: 424-435.
15. Easley R, Carpio L, Dannenberg L et al. (2010) Transcription through the HIV-1 nucleosomes: effects of the PBAF complex in Tat activated transcription. Virology 405: 322-333.
16. Han Y, Wind-Rotolo M, Yang HC, Siliciano JD & Siliciano RF (2007) Experimental approaches to the study of HIV-1 latency. Nat Rev Microbiol 5: 95-106.
17. Imai K & Okamoto T (2006) Transcriptional repression of human immunodeficiency virus type 1 by AP-4. J Biol Chem 281: 12495-12505.
18. Imai K, Togami H & Okamoto T (2010) Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294. J Biol Chem 285: 16538-16545.
19. Jiang G, Espeseth A, Hazuda DJ & Margolis DM (2007) c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter. J Virol 81: 10914-10923.
20. Jordan A, Bisgrove D & Verdin E (2003) HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J 22: 1868-1877.
21. Kauder SE, Bosque A, Lindqvist A, Planelles V & Verdin E (2009) Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog 5: e1000495.
22. Keedy KS, Archin NM, Gates AT, Espeseth A, Hazuda DJ & Margolis DM (2009) A limited group of class I histone deacetylases acts to repress human immunodeficiency virus type 1 expression. J Virol 83: 4749-4756.
23. Lassen K, Han Y, Zhou Y, Siliciano J & Siliciano RF (2004) The multifactorial nature of HIV-1 latency. Trends Mol Med 10: 525-531.
24. Lewinski MK, Bisgrove D, Shinn P et al. (2005) Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J Virol 79: 6610-6619.
25. Lusic M, Marcello A, Cereseto A & Giacca M (2003) Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter. EMBO J 22: 6550-6561.
26. MacLeod MK, Kappler JW & Marrack P (2010) Memory CD4 T cells: generation, reactivation and re-assignment. Immunology 130: 10-15.
27. Mahmoudi T, Parra M, Vries RG, Kauder SE, Verrijzer CP, Ott M & Verdin E (2006) The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoter. J Biol Chem 281: 19960-19968.
28. Maison C & Almouzni G (2004) HP1 and the dynamics of heterochromatin maintenance. Nat Rev Mol Cell Biol 5: 296-304.
29. Marban C, Redel L, Suzanne S et al. (2005) COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells. Nucleic Acids Res 33: 2318-2331.
30. Marban C, Suzanne S, Dequiedt F et al. (2007) Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. EMBO J 26: 412-423.
31. Marini A, Harper JM & Romerio F (2008) An in vitro system to model the establishment and reactivation of HIV-1 latency. J Immunol 181: 7713-7720.
32. Marrack P & Kappler J (2004) Control of T cell viability. Annu Rev Immunol 22: 765-787.
33. Marsili G, Remoli AL, Sgarbanti M & Battistini A (2004) Role of acetylases and deacetylase inhibitors in IRF-1-mediated HIV-1 long terminal repeat transcription. Ann N Y Acad Sci 1030: 636-643.
34. Mateescu B, Bourachot B, Rachez C, Ogryzko V & Muchardt C (2008) Regulation of an inducible promoter by an HP1beta-HP1gamma switch. EMBO Rep 9: 267-272.
35. Messi M, Giacchetto I, Nagata K, Lanzavecchia A, Natoli G & Sallusto F (2003) Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes. Nat Immunol 4: 78-86.
36. Perelson AS, Neumann AU, Markowitz M, Leonard JM & Ho DD (1996) HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271: 1582-1586.
37. Perelson AS, Essunger P & Ho DD (1997a) Dynamics of HIV-1 and CD4+ lymphocytes in vivo. AIDS 11(Suppl A): S17-S24.
38. Perelson AS, Essunger P, Cao Y et al. (1997b) Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387: 188-191.
39. Pierson TC, Zhou Y, Kieffer TL, Ruff CT, Buck C & Siliciano RF (2002) Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection. J Virol 76: 8518-8531.
40. Rafati H, Parra M, Hakre S, Moshkin Y, Verdin E & Mahmoudi T (2011) Repressive LTR Nucleosome Positioning by the BAF Complex Is Required for HIV Latency. PLoS Biol 9: e1001206.
41. Robison AJ & Nestler EJ (2011) Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 12: 623-637.
42. Sahu GK, Lee K, Ji J, Braciale V, Baron S & Cloyd MW (2006) A novel in vitro system to generate and study latently HIV-infected long-lived normal CD4+ T-lymphocytes. Virology 355: 127-137.
43. Saleh S, Solomon A, Wightman F, Xhilaga M, Cameron PU & Lewin SR (2007) CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency. Blood 110: 4161-4164.
44. Siliciano JD, Kajdas J, Finzi D et al. (2003) Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med 9: 727-728.
45. Swiggard WJ, Baytop C, Yu JJ et al. (2005) Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli. J Virol 79: 14179-14188.
46. Treand C, du Chene I, Bres V, Kiernan R, Benarous R, Benkirane M & Emiliani S (2006) Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter. EMBO J 25: 1690-1699.
47. Tyagi M & Karn J (2007) CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency. EMBO J 26: 4985-4995.
48. Tyagi M, Pearson RJ & Karn J (2010) Establishment of HIV latency in primary CD4+ cells is due to epigenetic transcriptional silencing and P-TEFb restriction. J Virol 84: 6425-6437.
49. Van Lint C, Emiliani S, Ott M & Verdin E (1996) Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J 15: 1112-1120.
50. Wang FX, Xu Y, Sullivan J et al. (2005) IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART. J Clin Invest 115: 128-137.
51. Williams SA, Chen LF, Kwon H, Ruiz-Jarabo CM, Verdin E & Greene WC (2006) NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J 25: 139-149.
52. Yang HC, Xing S, Shan L et al. (2009) Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. J Clin Invest 119: 3473-3486.
53. Yoder A, Yu D, Dong L et al. (2008) HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells. Cell 134: 782-792.
54. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A & Chen IS (1990) HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61: 213-222.